articleTop 1% cited
Expression of P-glycoprotein in Human Placenta: Relation to Genetic Polymorphism of the Multidrug Resistance (MDR)-1 Gene
Journal of Pharmacology and Experimental Therapeutics · 2001 · Vol. 297(3) · pp. 1137–1143
Mizuho Tanabe✉(Kyushu University)Ichiro Ieiri(Tottori University)Naoki Nagata(Tottori University)Kazuko Inoue(Tottori University)Soichiro Ito(Kyushu University)Yasunobu Kanamori(Tottori University)Masakuni Takahashi(Tottori University)Yasuo Kurata(Kyushu University)Junzo Kigawa(Tottori University)Shun Higuchi(Kyushu University)Naoki Terakawa(Tottori University)Kenji Otsubo(Tottori University)
Drug Transport and Resistance MechanismsPharmacological Effects and Toxicity StudiesPregnancy and Medication ImpactBiologySingle-nucleotide polymorphismGenotypeGenotypingMolecular biologyGeneticsAlleleGenegenomic DNARestriction fragment length polymorphism
MeSH terms
AllelesDNA Mutational AnalysisFemaleGene FrequencyGenotypeHumansImmunohistochemistryJapanGenetic LinkagePlacentaPolymorphism, Restriction Fragment LengthBlotting, WesternPolymerase Chain ReactionGenes, MDRAmino Acid Substitution
Citations
535
FWCI
15.63
field-weighted impact
References
25
Percentile
100%
vs. same field & year
Citations per year
Cited by
Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance
Clinical Pharmacology & Therapeutics · 2004 · 891 citations
Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: Consequences for pravastatin pharmacokinetics
Clinical Pharmacology & Therapeutics · 2003 · 511 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
